Save Ceftolozane/Tazobactam for Resistant E. coli or Pseudomonas
Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa).
It's approved for complicated UTIs (cUTIs) and intra-abdominal infections (cIAIs) in adults. And higher doses are also being studied for ventilator-associated pneumonia.
Ceftolozane/tazobactam primarily covers gram-negative bacteria...including Pseudomonas and ESBL-producing Enterobacteriaceae.